Similar articles

• [The value of chemotherapeutic intervention on primary hyperlipidemias in the prevention of coronary arteriosclerosis].

  Forti N, Dereviacki BE, Giannini SD. Forti N, et al. Arq Bras Cardiol. 1988 Jul;51(1):49-53. Arq Bras Cardiol. 1988. PMID: 3073736 Review. Portuguese. No abstract available.
• [Anti-atherogenic drugs].

  Kanaki T, Saito Y. Kanaki T, et al. Nihon Rinsho. 1998 Oct;56(10):2635-9. Nihon Rinsho. 1998. PMID: 9796331 Review. Japanese.
• [Treatment of high blood cholesterol in patients with coronary heart disease].

  Nagai Y, Yamashita S. Nagai Y, et al. Nihon Rinsho. 2003 Apr;61 Suppl 4:675-81. Nihon Rinsho. 2003. PMID: 12735049 Review. Japanese. No abstract available.
• [Treatment of high blood cholesterol in patients with coronary heart disease].

  Nagai Y, Yanagi K, Yamashita S, Takemura K, Matsuzawa Y. Nagai Y, et al. Nihon Rinsho. 1994 Jul;52 Suppl(Pt 1):1088-94. Nihon Rinsho. 1994. PMID: 12436661 Review. Japanese. No abstract available.
• Angiographic trials of lipid-lowering therapy: an update.

  Mancini GB. Mancini GB. Curr Opin Lipidol. 1995 Dec;6(6):379-85. doi: 10.1097/00041433-199512000-00009. Curr Opin Lipidol. 1995. PMID: 8750252 Review.